Table 3.

Sensitivity analysis: Logistic regression modeling for cancer-specific outcomes in 77 lymph node positive patients ≤ 2 years after radical cystectomy and bilateral pelvic lymph node dissection.

	Univariate			Multivariable*
	OR	95% CI	p-value	OR	95% CI	p-value
Disease Recurrence
Adjuvant chemotherapy		Ref.			Ref.
Neoadjuvant chemotherapy	5.29	1.89, 14.83	0.002	5.59	1.95, 16.01	0.001
Cancer-Specific Mortality
Adjuvant chemotherapy		Ref.			Ref.
Neoadjuvant chemotherapy	4.28	1.59, 11.50	0.004	5.24	1.78, 15.46	0.003

^*Model adjusted for pathological stage (≤pT2, pT3, pT4) and LN density.